Acute ischemic stroke treatment in a nutshell
Acute ischemic stroke treatment in a nutshell
Acute ischemic stroke treatment in a nutshell
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
WARFARIN<br />
Secondary prevention: Prior TIA or m<strong>in</strong>or <strong>stroke</strong> (EAFT)<br />
• Warfar<strong>in</strong> (INR 2.5 to 4.0) vs placebo<br />
Effective NNT over 2 y = 6-7<br />
• Aspir<strong>in</strong> 300 mg om vs placebo<br />
Safe alternative NNT over 2 y = 50<br />
• Warfar<strong>in</strong> vs Aspir<strong>in</strong><br />
Warfar<strong>in</strong> superior NNT over 2 y =7-8<br />
At 28<br />
months<br />
Warfar<strong>in</strong><br />
Placebo<br />
P value<br />
Aspir<strong>in</strong><br />
Placebo<br />
P value<br />
Stroke<br />
8.9%<br />
23.4%<br />